CTRI/2012/04/002546已完成未知
A randomized, open label study to determine the relative bioavailability of inhaled indacaterol given with and without oral activated charcoal for two formulations of indacaterol- lactose blend formulation and Pulmosphere based formulation in healthy adult subjects.
ovartis Healthcare Private Limited0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Ba/be
入排标准
入选标准
- •1. Healthy male and female subjects
- •2. Subjects must weigh at least 50 kg and their BMI should be within range of 18-30 kg/m2
- •3. Women of child-bearing potential must use effective contraception during the study.
排除标准
- •1. Smokers
- •2. History of hypersensitivity to any of the study drugs or to drugs of similar chemical classes
- •3. Pregnant or nursing (lactating) women
- •4. A positive Hepatitis B surface antigen (HBsAg) or Hepatitis C test result, HIV test
- •5. History of clinically significant ECG abnormalities, malignancy of any organ system, history of immunodeficiency diseases; of drug or alcohol abuse.
研究者
相似试验
已完成
1 期
To determine the relative concentration of inhaled indacaterol maleate (with andwithout oral activated charcoal) in blood of the subjects through concept1 device and the EPIC TestFixture in healthy adult subjects.CTRI/2013/07/003811ovartis Healthcare Private Limited24
招募中
不适用
An open-label, randomized study to assess the relative bioavailability (BA) and bioequivalence (BE) of fixed-dose combination (FDC) formulations of niraparib plus abiraterone acetate (AA) compared to niraparib and AA co-administered as single agents in men with prostate cancerprostate carcinoma10038597prostate cancerNL-OMON52439Janssen-Cilag15
进行中（未招募）
不适用
Treatment of patients, who have Mucopolysaccharidosis Type I, receiving pentosan polysulfate subcutaneous injections weeklyMucopolysaccharidosis type I (alpha-L-Iduronidase deficiency)MedDRA version: 17.0Level: LLTClassification code 10056888Term: Mucopolysaccharidosis ISSystem Organ Class: 100000004850MedDRA version: 17.0Level: LLTClassification code 10056887Term: Mucopolysaccharidosis IH/SSystem Organ Class: 100000004850MedDRA version: 17.0Level: LLTClassification code 10028094Term: Mucopolysaccharidosis IHSystem Organ Class: 100000004850EUCTR2014-000350-11-DEMultiplex Pharma Holdings LLC6
招募中
1 期
A Non-Randomized, Open-Label Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination.Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPVMedDRA version: 20.1Level: LLTClassification code: 10063001Term: Human papilloma virus infection Class: 10021881CTIS2024-515228-36-00Bellvitge University Hospital69
进行中（未招募）
1 期
A Non-Randomized, Open-Label Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination.Human PapillomavirusMedDRA version: 20.1Level: LLTClassification code 10063001Term: Human papilloma virus infectionSystem Organ Class: 100000004862EUCTR2021-005229-26-ESDr. Miguel Angel Pavón Ribas69